RxDoctor Payments Data

Mary Ella Carter, MD

Plastic Surgery · Washington, DCNPI 1194750224

Payments from drug & device makers

What this record shows

17 manufacturers reported payments, led by Integra Lifesciences Corporation at 55.6% of the total. 2025 is the largest year on record at $2,036, more than ten times the $80 reported in 2019. That places this record below the midpoint for plastic surgery clinicians in DC, where the typical reported total is $3,571.

$3,571in general payments, 2019–2025

Across 57 payments — averaging $62.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$2K
  • AbbVie$395
  • Kerecis Limited$177
  • Baxter Healthcare$171
  • Revance Therapeutics, Inc.$160
  • TELA Bio, Inc.$127
  • plus $555 from 11 others

What the payments were for

  • Food & beverage$2,06958%
  • Other$1,50242%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,571 in reported general payments places this provider in the 50th percentile of 34 plastic surgery providers in District of Columbia.

See all plastic surgery providers in District of Columbia

Medicare billing

Part B allowed, 2024
$1,380,094
Medicare patients
1,006
Services billed
7,506

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin540$4,995
Doxycycline Hyclate155$1,831
Clobetasol Propionate43$1,579
Cephalexin56$919
Silver Sulfadiazine95$753
SsdSilver Sulfadiazine41$424
Gentamicin Sulfate11$424
ErythromycinErythromycin Base20$189
Tramadol Hcl81$179
Methylprednisolone11$85
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen24$82
Ondansetron OdtOndansetron11$43

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →